Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib dosing schedules in advanced breast cancer
NCT00089999Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2004
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by GSK. Started Jun 2004; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00089999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089999.